SHP2 deficiency promotes Staphylococcus aureus pneumonia following influenza infection

Area of Science:

• Immunology
• Microbiology
• Molecular Biology

Background:

• Secondary bacterial pneumonia frequently complicates influenza infections.
• The molecular mechanisms driving post-influenza bacterial pneumonia are not fully understood.
• SHP2's role in the immune response to secondary bacterial infections requires elucidation.

Purpose of the Study:

• To investigate the role of SHP2 in the host's defense against secondary Staphylococcus aureus pneumonia following influenza.
• To elucidate the molecular mechanisms by which SHP2 influences immune cell function and bacterial clearance in this context.

Main Methods:

• A mouse model of post-influenza S. aureus pneumonia was established using conditional Shp2 knockout mice (LysM^Cre/+ :Shp2^flox/flox).
• Assessment of survival, bacterial clearance, pulmonary histology, macrophage phenotype, and immune mediator expression (type I interferons, chemokines KC and MIP-2).
• In vitro analysis of SHP2-deficient macrophages and investigation of signaling pathways (MAPKs, NF-κB, IRF3).

Main Results:

• Shp2 knockout mice exhibited significantly impaired antibacterial immunity, reduced bacterial clearance, and increased mortality compared to controls.
• SHP2 deficiency led to increased type I interferon production and decreased chemokine expression, impairing neutrophil infiltration.
• Macrophages lacking SHP2 showed enhanced M2 polarization and reduced antibacterial capacity, with altered NF-κB and IRF3 signaling.

Conclusions:

• SHP2 expression is essential for mounting an effective host immune response against secondary S. aureus pneumonia post-influenza.
• SHP2 promotes bacterial clearance by modulating macrophage polarization and inflammatory signaling pathways.
• Targeting SHP2 may represent a therapeutic strategy to enhance host defense in post-influenza bacterial pneumonia.